FOLH1 and prostate adenocarcinoma: Prostate-specific membrane antigen (PSMA) is a 100-kDa transmembrane peptidase expressed in prostate epithelium that is upregulated in prostate adenocarcinoma and has a positive association with tumor aggressiveness markers such as the Gleason score (4, 5).